Cubist Systematic Strategies’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.32M Buy
+37,434
New +$1.29M 0.01% 1811
2025
Q2
Sell
-231,480
Closed -$7.47M 2949
2025
Q1
$7.47M Buy
+231,480
New +$8.59M 0.05% 651
2024
Q2
Sell
-152,931
Closed -$4.65M 2968
2024
Q1
$4.65M Sell
152,931
-60,470
-28% -$2.03M 0.03% 1004
2023
Q4
$7.62M Buy
213,401
+130,522
+157% +$4.85M 0.05% 609
2023
Q3
$3.63M Sell
82,879
-51,798
-38% -$2.53M 0.03% 956
2023
Q2
$6.65M Buy
134,677
+23,767
+21% +$1.1M 0.04% 669
2023
Q1
$4.6M Buy
110,910
+54,074
+95% +$2.24M 0.03% 999
2022
Q4
$2.52M Buy
56,836
+10,142
+22% +$424K 0.01% 1659
2022
Q3
$1.83M Buy
46,694
+16,145
+53% +$739K 0.01% 2103
2022
Q2
$1.25M Buy
30,549
+26,644
+682% +$1.26M 0.01% 2282
2022
Q1
$256K Sell
3,905
-13,534
-78% -$877K ﹤0.01% 2928
2021
Q4
$1.21M Buy
17,439
+12,353
+243% +$898K 0.01% 1769
2021
Q3
$354K Sell
5,086
-5,401
-52% -$416K ﹤0.01% 2250
2021
Q2
$832K Buy
+10,487
New +$762K 0.01% 1705
2021
Q1
Sell
-13,105
Closed -$730K 2822
2020
Q4
$730K Buy
+13,105
New +$567K 0.01% 1568
2020
Q3
Sell
-29,551
Closed -$1.33M 2479
2020
Q2
$1.33M Buy
29,551
+20,267
+218% +$882K 0.02% 1015
2020
Q1
$312K Buy
9,284
+6,149
+196% +$221K 0.01% 1496
2019
Q4
$102K Sell
3,135
-12,214
-80% -$348K ﹤0.01% 2184
2019
Q3
$383K Buy
+15,349
New +$438K 0.01% 1423
2018
Q4
Sell
-421
Closed -$15K 2043
2018
Q3
$15K Buy
+421
New +$13.3K ﹤0.01% 1803
2017
Q4
Sell
-2,961
Closed -$66K 1899
2017
Q3
$66K Buy
2,961
+660
+29% +$14.9K ﹤0.01% 1699
2017
Q2
$56K Buy
+2,301
New +$48.9K ﹤0.01% 1533

Other funds holding ATRC

Cubist Systematic Strategies's ATRC Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in AtriCure (ATRC) in Q3 2025: 37,434 shares worth $1.32M. The stake represents 0.01% of the portfolio and ranks #1811 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in ATRC as recently as Q1 2025.

Cubist Systematic Strategies first reported a position in ATRC in Q2 2017 and has held it in 22 quarters since. The position peaked at $7.62M in Q4 2023. 223 funds tracked by Wall St. Rank hold ATRC as of Q3 2025.

  • Cubist Systematic Strategies held 37,434 shares of AtriCure worth $1.32M as of Q3 2025.
  • AtriCure was a new Cubist Systematic Strategies position in Q3 2025.
  • AtriCure made up 0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1811 holding.
  • Cubist Systematic Strategies first reported a position in AtriCure in Q2 2017 and has held it in 22 quarters since.
  • Cubist Systematic Strategies's AtriCure position peaked at $7.62M in Q4 2023.
  • 223 funds tracked by Wall St. Rank held AtriCure as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.